Lilly
Market Reports 📊 91 Reports
76. Continuous Glucose Monitoring: The Current State of the Art
This report is designed to investigate and discuss the latest developments in continuous glucose monitoring (CGM) for the management of diabetes.
77. Health Technology Assessment in Pharma: A Review of Major Decisions
The report provides a detailed outlook on the HTA process and approvals in major economies. Helps in understanding the HTA needs by region and provides insights on the recent HTA submissions to HTA ag
78. Stress Management Industry: Global Trends
The global stress management treatments market should reach $20.6 billion by 2024 from $17.2 billion in 2019 at a compound annual growth rate (CAGR) of 3.7% for the forecast period of 2019 to 2024.
79. Latest Development, Product Innovations and Treatments for Diabetes
The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rate (CAGR) of 5.0% for the period of 2019-2024.
80. ROI in Pharmaceutical R&D: How to Halt the Decline
The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.
81. Pediatric Medicines: Global Markets
Get an overview of the global markets for pediatric medicines within the pharmaceutical industry. Analyses of the global market trends, with data from 2018, estimates for 2019, and projections of comp
82. Breast Cancer Diagnostic and Drug Technologies: Global Markets
BCC Research Market Research Report on Breast Cancer Diagnostic and Drug Technologies Market size, growth, trends and forecast for 2024. This Market should reach $28.2 billion by 2024 from $20.9 billi
83. Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies should grow from $346 billion in 2019 to $490 billion by 2024, at a compound annual growth rate (CAGR) of 7.2% fro
84. Neurology Market: A BCC Research Overview
The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.
85. Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
Explore the global market for radiotherapy, radiopharmaceuticals & nuclear medicines and examine the future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both d
86. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
87. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
88. Global Tumor-specific Antigen Market
The global market for tumor-specific antigen should grow from $1.7 billion in 2017 to reach $2.4 billion by 2023 at a CAGR of 6.2% for the period of 2018-2023.
89. Chronic Kidney Disease: Global Markets and Technologies Through 2023
According to BCC Research global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate of 3.8%.
90. Colorectal Cancer Therapeutics: Global Markets
The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate of 6.1% for the period 2018 to 2023.
91. Antihypertensives: Global Markets to 2023
The global market for antihypertensive drugs should grow from nearly $26.3 billion in 2018 to $27.8 billion by 2023 with a compound annual growth rate (CAGR) of 1.1% for the period of 2018-2023.